Changes in respiratory control induced by amino acid infusions

J. Takala, J. Askanazi, C. Weissman, Patrick A. LaSala, J. Milic-Emili, D. H. Elwyn, J. M. Kinney

Research output: Contribution to journalArticle

35 Citations (Scopus)

Abstract

We compared the metabolic and respiratory responses to a 4-h infusion of an amino acid solution consisting primarily of branched-chain amino acids (BCAA) to those after a standard amino acid solution in healthy subjects. Both the BCAA solution and the standard amino acid solution increased minute ventilation (mean increase 22%, p < .001, and 18%, p < .01, respectively), mean inspiratory flow (19%, p < .01 and 19%, p < .05) and oxygen consumption (9%, p < .02, and 5%, NS). PaCO2 decreased (mean decrease 6%, p < .01); there was a major increase in the ventilatory response to CO2 inhalation during administration of the BCAA solution but not the standard amino acid solution. Increased plasma norepinephrine concentration (mean increase 75%, p < .001) during the infusion of the standard amino acid solution but not the BCAA solution suggested the increased sympathetic activity. The results demonstrate augmented respiratory effects of amino acid infusions by BCAA enrichment, and a dissociation between the respiratory stimulation, metabolic rate, and sympathetic activity.

Original languageEnglish (US)
Pages (from-to)465-469
Number of pages5
JournalCritical Care Medicine
Volume16
Issue number5
StatePublished - 1988
Externally publishedYes

Fingerprint

Branched Chain Amino Acids
Amino Acids
Inhalation Administration
Oxygen Consumption
Ventilation
Norepinephrine
Healthy Volunteers

ASJC Scopus subject areas

  • Critical Care and Intensive Care Medicine

Cite this

Takala, J., Askanazi, J., Weissman, C., LaSala, P. A., Milic-Emili, J., Elwyn, D. H., & Kinney, J. M. (1988). Changes in respiratory control induced by amino acid infusions. Critical Care Medicine, 16(5), 465-469.

Changes in respiratory control induced by amino acid infusions. / Takala, J.; Askanazi, J.; Weissman, C.; LaSala, Patrick A.; Milic-Emili, J.; Elwyn, D. H.; Kinney, J. M.

In: Critical Care Medicine, Vol. 16, No. 5, 1988, p. 465-469.

Research output: Contribution to journalArticle

Takala, J, Askanazi, J, Weissman, C, LaSala, PA, Milic-Emili, J, Elwyn, DH & Kinney, JM 1988, 'Changes in respiratory control induced by amino acid infusions', Critical Care Medicine, vol. 16, no. 5, pp. 465-469.
Takala J, Askanazi J, Weissman C, LaSala PA, Milic-Emili J, Elwyn DH et al. Changes in respiratory control induced by amino acid infusions. Critical Care Medicine. 1988;16(5):465-469.
Takala, J. ; Askanazi, J. ; Weissman, C. ; LaSala, Patrick A. ; Milic-Emili, J. ; Elwyn, D. H. ; Kinney, J. M. / Changes in respiratory control induced by amino acid infusions. In: Critical Care Medicine. 1988 ; Vol. 16, No. 5. pp. 465-469.
@article{75e4ce766c2a4a4f88c535c2b1eb694a,
title = "Changes in respiratory control induced by amino acid infusions",
abstract = "We compared the metabolic and respiratory responses to a 4-h infusion of an amino acid solution consisting primarily of branched-chain amino acids (BCAA) to those after a standard amino acid solution in healthy subjects. Both the BCAA solution and the standard amino acid solution increased minute ventilation (mean increase 22{\%}, p < .001, and 18{\%}, p < .01, respectively), mean inspiratory flow (19{\%}, p < .01 and 19{\%}, p < .05) and oxygen consumption (9{\%}, p < .02, and 5{\%}, NS). PaCO2 decreased (mean decrease 6{\%}, p < .01); there was a major increase in the ventilatory response to CO2 inhalation during administration of the BCAA solution but not the standard amino acid solution. Increased plasma norepinephrine concentration (mean increase 75{\%}, p < .001) during the infusion of the standard amino acid solution but not the BCAA solution suggested the increased sympathetic activity. The results demonstrate augmented respiratory effects of amino acid infusions by BCAA enrichment, and a dissociation between the respiratory stimulation, metabolic rate, and sympathetic activity.",
author = "J. Takala and J. Askanazi and C. Weissman and LaSala, {Patrick A.} and J. Milic-Emili and Elwyn, {D. H.} and Kinney, {J. M.}",
year = "1988",
language = "English (US)",
volume = "16",
pages = "465--469",
journal = "Critical Care Medicine",
issn = "0090-3493",
publisher = "Lippincott Williams and Wilkins",
number = "5",

}

TY - JOUR

T1 - Changes in respiratory control induced by amino acid infusions

AU - Takala, J.

AU - Askanazi, J.

AU - Weissman, C.

AU - LaSala, Patrick A.

AU - Milic-Emili, J.

AU - Elwyn, D. H.

AU - Kinney, J. M.

PY - 1988

Y1 - 1988

N2 - We compared the metabolic and respiratory responses to a 4-h infusion of an amino acid solution consisting primarily of branched-chain amino acids (BCAA) to those after a standard amino acid solution in healthy subjects. Both the BCAA solution and the standard amino acid solution increased minute ventilation (mean increase 22%, p < .001, and 18%, p < .01, respectively), mean inspiratory flow (19%, p < .01 and 19%, p < .05) and oxygen consumption (9%, p < .02, and 5%, NS). PaCO2 decreased (mean decrease 6%, p < .01); there was a major increase in the ventilatory response to CO2 inhalation during administration of the BCAA solution but not the standard amino acid solution. Increased plasma norepinephrine concentration (mean increase 75%, p < .001) during the infusion of the standard amino acid solution but not the BCAA solution suggested the increased sympathetic activity. The results demonstrate augmented respiratory effects of amino acid infusions by BCAA enrichment, and a dissociation between the respiratory stimulation, metabolic rate, and sympathetic activity.

AB - We compared the metabolic and respiratory responses to a 4-h infusion of an amino acid solution consisting primarily of branched-chain amino acids (BCAA) to those after a standard amino acid solution in healthy subjects. Both the BCAA solution and the standard amino acid solution increased minute ventilation (mean increase 22%, p < .001, and 18%, p < .01, respectively), mean inspiratory flow (19%, p < .01 and 19%, p < .05) and oxygen consumption (9%, p < .02, and 5%, NS). PaCO2 decreased (mean decrease 6%, p < .01); there was a major increase in the ventilatory response to CO2 inhalation during administration of the BCAA solution but not the standard amino acid solution. Increased plasma norepinephrine concentration (mean increase 75%, p < .001) during the infusion of the standard amino acid solution but not the BCAA solution suggested the increased sympathetic activity. The results demonstrate augmented respiratory effects of amino acid infusions by BCAA enrichment, and a dissociation between the respiratory stimulation, metabolic rate, and sympathetic activity.

UR - http://www.scopus.com/inward/record.url?scp=0023945053&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023945053&partnerID=8YFLogxK

M3 - Article

VL - 16

SP - 465

EP - 469

JO - Critical Care Medicine

JF - Critical Care Medicine

SN - 0090-3493

IS - 5

ER -